Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maribavir vs Ganciclovir for CMV Prophylaxis in Liver Transplant
NCT00497796Phase 3Completed
- Sponsor
- Takeda
- Start
- Jul 2007
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of maribavir in cytomegalovirus disease (CMV), sponsored by Takeda. Started Jul 2007; status: completed.
02
Drugs
maribavir
03
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on NCT00497796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00497796.